Find a Doctor or Practice Location

You can also search for providers and practices at Penn Medicine Lancaster General Health or Princeton Health.

within
I am searching for a
Reset Form
Corey J. Langer, MD

Corey J. Langer, MD Physician

Director, Thoracic Oncology Professor of Medicine at the Hospital of the University of Pennsylvania

Dr. Langer is employed by Penn Medicine.

About Dr. Corey J. Langer

Recognized by America's Top Doctors, 2008, 2010 - 2018

Recognized by Best Doctors in America 2009, 2010, 2013 - 2018

Recognized annually in Philadelphia magazine's Top Docs issue, 2009 - 2019

Patient Satisfaction Ratings

Patient Rating Breakdown

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Overall Ratings

Clinical Specialties

Specialty:

  • Medical Oncology

Programs & Centers:

Board Certification:

  • Hematology, 1986
  • Internal Medicine, 1984
  • Medical Oncology, 1987

Clinical Expertise:

  • Adenocarcinoma of Lung
  • Adenocarcinoma of the Head and Neck
  • Adenoid Cystic Carcinoma
  • Anaplastic Cancer of Thyroid
  • Base of Skull Tumors
  • Biological Targeted Therapy
  • Cancer Chemotherapy
  • Cancer of the Hard/Soft Palate
  • Cancer of the Nasal Cavity
  • Cancer of the Parotid
  • Cancer of the Supraglottis
  • Cancer of the Vocal Cords
  • Diaphragm Tumor
  • Ear and Temporal Bone Tumors
  • Esophageal Cancer
  • Follicular Cancer of Thyroid
  • Glottic Cancer
  • Head and Neck Melanoma
  • Head and Neck Sarcoma
  • Head and Neck Tumor
  • Hurthle Cell Cancer
  • Hypopharyngeal Cancer
  • Immunotherapy
  • Jaw Cancer
  • Large Cell Cancer of the Lung
  • Laryngeal Cancer
  • Lung Carcinoid Tumor
  • Medullary Cancer of Thyroid
  • Merkel Cell Carcinoma
  • Mesothelioma
  • Metastatic Squamous Neck Cancer with Occult Primary
  • Mouth Cancer (Oral Cancer)
  • Nasal Cavity and Paranasal Sinus Cancer
  • Nasopharyngeal Cancer
  • Neck Cancer
  • Non-Small Cell Lung Cancer
  • Oropharyngeal Cancer
  • Papillary Cancer of Thyroid
  • Parathyroid Cancer
  • Pituitary Cancer
  • Pleural Cancer
  • Salivary Gland Cancer
  • Sarcoma of the Lung
  • Sinus Cancer
  • Small Cell Lung Cancer
  • Squamous Cancer of the Lung
  • Squamous Cell Carcinoma of the Esophagus
  • Squamous Cell Carcinoma of the Head and Neck
  • Squamous Cell Carcinoma of the Mouth
  • Squamous Cell Carcinoma of the Throat
  • Squamous Cell Carcinoma of the Tonsils
  • Temporal Bone Cancer
  • Thoracic Cancer
  • Throat Cancer
  • Thymoma and Thymic Carcinoma
  • Tongue Cancer
  • Tonsil Cancer
  • Tracheal Cancer
  • Tumor of Parotid Gland
Show All Expertise

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Amerihealth Caritas
  • Amerihealth Caritas Medicare
  • Cigna
  • Cigna HealthSpring
  • Clover Health Plan
  • CVS Health
  • Devon Health Services (Americare)
  • eLAP Services
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Homestead Smart Health Plans
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oscar Health Plan of PA
  • Oxford Health Plan
  • PA Health and Wellness (Centene) Medicare
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Provider Partners Health Plan
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan
  • Veterans Choice Program

Education and Training

Medical School: Boston University School of Medicine
Residency: Graduate Hospital
Fellowship: Penn Presbyterian Medical Center
Fellowship: Fox Chase Cancer Center

Memberships

AACR, National American Association for Cancer Research, (Member), National American College of Physicians, National American College of Surgeons Head and Neck Database Committee, National American Society of Clinical Oncology, National BMS Advisory Board on Ipilimumab, National Eastern Cooperative Oncology Group (ECOG), Member of Elderly Working Group, National Gilead Pharmaceuticals, International International Association for Study of Lung Cancer, International Lung Cancer Partnership, Local National Comprehensive Cancer Network Non-Small Cell Lung Cancer Panel, National National Comprehensive Cancer Network Small Cell Lung Cancer Panel, National Oncology Physician Network (OPN), Inc., Philadelphia, Local Pennsylvania Medical Society, Local Program Committee of the International Association of Lung Cancer, International

Hospital Affiliation

Dr. Langer is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.

Research

Selected Publications:

Aggarwal C, Thompson JC, Black TA, Katz SI, Fan R, Yee SS, Chien AL, Evans TL, Bauml JM, Alley EW, Ciunci CA, Berman AT, Cohen RB, Lieberman DB, Majmundar KS, Savitch SL, Morrissette JJD, Hwang WT, Elenitoba-Johnson KSJ, Langer CJ, Carpenter EL: Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non-Small Cell Lung Cancer JAMA Oncol. 5 (2): 173-180,2019.

Langer, CJ; Redman, MW; Wade, JL; Aggarwal, C; Bradley, JD; Crawford, J; Stella, PJ; Knapp, MH; Miao, J; Minichiello, K; Herbst, RS; Kelly, K; Gandara, DR; Papadimitrakopoulou, VA: SWOG S1400B (NCT02785913), a Phase II Study of GDC-0032 (Taselisib) for Previously Treated PI3K-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study) J Thorac Oncol 14 (10): 1839-1846,2019.

Grewal AS, Min EJ, Long Q, Grewal SK, Jain V, Levin WP, Cengel KA, Swisher-McClure S, Aggarwal C, Bauml JM, Singh A, Ciunci C, Cohen RB, Langer CJ, Feigenberg SJ, Berman AT: Early Tumor and Nodal Response in Patients with Locally-advanced NSCLC Predict for Oncologic Outcomes in Patients Treated with Concurrent Proton Therapy and Chemotherapy Int J Radiat Oncol Biol Phys : 2019.

Ramesh Rengan, MD, PhD; Rosemarie Mick, MS; Daniel A. Pryma, MD; Lilie Leming Lin, MD; John Christodouleas, MD; John P. Plastaras, MD, PhD;, Charles B. Simone II, MD; Anjali K. Gupta, MD; Tracey L. Evans, MD; James P. Stevenson, MD; Corey J. Langer, MD; John Kucharczuk, MD;, Joseph Friedberg, MD; Sarah Lam, BS; Dana Patsch, BS; Stephen M. Hahn, MD; Amit Maity, MD, PhD: Clinical Outcomes of the HIV Protease Inhibitor Nelfinavir with Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non–Small Cell Lung Cancer A Phase 1/2 Trial JAMA Oncology 5 (10): 1464-1472,2019.

Lenderking WR, Lin H, Speck RM, Zhu Y2, Huang H, Huang J, Kerstein D, Langer CJ: Patient-reported Outcomes and Quality of Life in Advanced ALK+ Non-Small-Cell Lung Cancer Trial of Brigatinib (ALTA) Future Oncol 15 (24): 2841-2855,2019.

Bagley SJ, Talento S, Mitra N, Meropol NJ, Cohen RB, Langer CJ, Vachani A: Comparative Effectiveness of Carboplatin/Pemetrexed With Versus Without Bevacizumab for Advanced Non-squamous Non-Small Cell Lung Cancer J Natl Compr Canc Netw 17 (5): 469-477,2019.

Bauml JM, Vinnakota R, Park Y-H A, Bates SE, Fojo T, Aggarwal C, Limaye S, Damjanov N, Di Stefano J, Ciunci C, Genden EM, Wisnivesky JP, Ferrandino R, Mamtani R, Langer CJ, Cohen RB, Sigel K: Cisplatin Every 3 Weeks Versus Weekly With Definitive Concurrent Radiotherapy for Squamous Cell Carcinoma of the Head and Neck J Natl Cancer Inst 111 (5): 490-497,2019.

Gubens MA, Sequist LCV, Stevenson JP, Powell SP, Villaruze LC, Gadgeel SM, Langer CJ, Patnaikh A, Borghaei H, Jalal SI, Fiorek J, Saraf S, Raftopoulos H, Gandhi L: Pembrolizumab in combination with ipilimumab as second-line or later therapy for advanced non–small-cell lung cancer: KEYNOTE-021 cohorts D and H Lung Cancer 130, 59-66. Apr 2019. 130 : 59-66,2019.

Bauml JM, Vinnakota R, Anna Park Y-H, Bates SE, Fojo T, Aggarwal CJDi Stefano J, Knepley C, Limaye S, Mamtani R, Wisnivesky J, Damjanov N, Langer CJ, Cohen RB, Sigel K: Cisplatin Versus Cetuximab With Definitive Concurrent Radiotherapy for Head and Neck Squamous Cell Carcinoma: An Analysis of Veterans Health Affairs Data Cancer 125 (3): 406-415,2019.

Charu Aggarwal, Jeffrey C Thompson, Taylor A Black, Sharyn I Katz, Ryan Fan, Stephanie S Yee, Austin L Chien, Tracey L Evans, Joshua M Bauml, Evan W Alley, Christine A Ciunci, Abigail T Berman, Roger B Cohen, David B Lieberman, Krishna S Majmundar, Samantha L Savitch, Jennifer J D Morrissette, Wei-Ting Hwang, Kojo S J Elenitoba-Johnson, Corey J Langer, Erica L Carpenter: Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non-Small Cell Lung Cancer JAMA Oncology 5 (2): 173-200,2019.

Academic Contact Info

Division of Hematology Oncology
Perelman Center for Advanced Medicine
10th Floor, South Pavilion
Office #10-206
3400 Civic Center Boulevard

Philadelphia, PA 19104
Phone: (215) 615-5121
Patient appointments: 800-789-7366 (PENN)

Related Links